Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1975
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search